Michelle Carbonneau1, Tracy Davyduke1, Stephen E Congly2, Mang M Ma3, Kim Newnham1, Vanessa Den Heyer1, Puneeta Tandon2,3, Juan G Abraldes2,3. 1. Hepatology Department, Alberta Health Services, Edmonton, Alberta, Canada. 2. Liver Unit, Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada. 3. Liver Unit, Division of Gastroenterology, Centre of Excellence for Gastrointestinal Inflammation and Immunity Research, University of Alberta, Edmonton, Alberta, Canada.
Abstract
Background: Multidisciplinary care has the potential to improve outcomes among patients with cirrhosis, yet its impact on this population remains unclear, with existing studies demonstrating discrepant results. Using data from the multidisciplinary outpatient Cirrhosis Care Clinic (CCC) at the University of Alberta Hospital, we aimed to evaluate acute care utilization and survival outcomes of patients followed by the CCC compared with those receiving standard care (SC). Methods: We performed a retrospective chart review of 212 patients with cirrhosis admitted to University of Alberta Hospital between 2014 and 2015. CCC patients (n = 36) were followed through the CCC before index admission. SC patients (n = 176) were managed outside of the CCC. Readmission time in hospital was collected until 1 year, death, or liver transplant. Results: CCC patients had more advanced liver disease (higher prevalence of ascites, encephalopathy, and varices). Despite this, acute care utilization was significantly lower among CCC patients (adjusted length of stay lower by 3 days, p = 0.03, and adjusted survival days spent in hospital lower by 9%, p = 0.02). CCC patients also had improved 1-year transplant-free survival, with an adjusted 1-year relative risk reduction of 53% (p = 0.03). Total mean cost of care was lower in the CCC group by $2,280 per patient-month of life. Discussion: For patients admitted with cirrhosis, specialized post-discharge multidisciplinary outpatient care is associated with decreased acute care utilization, improved 1-year transplant-free survival probability, and the potential for cost savings to the system.
Background: Multidisciplinary care has the potential to improve outcomes among patients with cirrhosis, yet its impact on this population remains unclear, with existing studies demonstrating discrepant results. Using data from the multidisciplinary outpatient Cirrhosis Care Clinic (CCC) at the University of Alberta Hospital, we aimed to evaluate acute care utilization and survival outcomes of patients followed by the CCC compared with those receiving standard care (SC). Methods: We performed a retrospective chart review of 212 patients with cirrhosis admitted to University of Alberta Hospital between 2014 and 2015. CCC patients (n = 36) were followed through the CCC before index admission. SC patients (n = 176) were managed outside of the CCC. Readmission time in hospital was collected until 1 year, death, or liver transplant. Results: CCC patients had more advanced liver disease (higher prevalence of ascites, encephalopathy, and varices). Despite this, acute care utilization was significantly lower among CCC patients (adjusted length of stay lower by 3 days, p = 0.03, and adjusted survival days spent in hospital lower by 9%, p = 0.02). CCC patients also had improved 1-year transplant-free survival, with an adjusted 1-year relative risk reduction of 53% (p = 0.03). Total mean cost of care was lower in the CCC group by $2,280 per patient-month of life. Discussion: For patients admitted with cirrhosis, specialized post-discharge multidisciplinary outpatient care is associated with decreased acute care utilization, improved 1-year transplant-free survival probability, and the potential for cost savings to the system.
Authors: Francisco Javier Martín-Sánchez; Virginia Carbajosa; Pere Llorens; Pablo Herrero; Javier Jacob; Òscar Miró; Cristina Fernández; Héctor Bueno; Elpidio Calvo; José Manuel Ribera Casado Journal: Gac Sanit Date: 2016-02-19 Impact factor: 2.139
Authors: Betty P Morales; Ramon Planas; Ramon Bartoli; Rosa M Morillas; Margarita Sala; Irma Casas; Carolina Armengol; Helena Masnou Journal: Dig Liver Dis Date: 2017-08-13 Impact factor: 4.088
Authors: Jasmohan S Bajaj; James B Wade; Douglas P Gibson; Douglas M Heuman; Leroy R Thacker; Richard K Sterling; R Todd Stravitz; Velimir Luketic; Michael Fuchs; Melanie B White; Debulon E Bell; HoChong Gilles; Katherine Morton; Nicole Noble; Puneet Puri; Arun J Sanyal Journal: Am J Gastroenterol Date: 2011-05-10 Impact factor: 10.864
Authors: Fasiha Kanwal; Jennifer R Kramer; Paula Buchanan; Steven M Asch; Youssef Assioun; Bruce R Bacon; Juan Li; Hashem B El-Serag Journal: Gastroenterology Date: 2012-03-28 Impact factor: 22.682
Authors: Elliot B Tapper; Shengchen Hao; Menghan Lin; John N Mafi; Heather McCurdy; Neehar D Parikh; Anna S Lok Journal: Hepatology Date: 2019-06-21 Impact factor: 17.425
Authors: Shantanu Solanki; Khwaja Fahad Haq; Raja Chandra Chakinala; Zubair Khan; Wilbert S Aronow; Muhammad Ali Khan; Mohamed Tausif Siddiqui; Khwaja Saad Haq; Shalom Frager; Maryam Alimirah; Christopher Nabors; David J Samson; Edward Lebovics; David Cary Wolf Journal: Ann Transl Med Date: 2019-09